Not Yet RecruitingNot Applicable

The Role of Autoantibodies Against G-protein Coupled Receptors in Obesity

Denmark160 participantsStarted 2026-09-01

Plain-language summary

The purpose of this study is to explore if GPCR-autoantibodies: 1. are pressent in people living with obesity, and are associated with degree of obesity 2. if it is associated with obesity related diseases

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Inhabitant in the Region of Southern Denmark * BMI above 30kg/m2 * age between 18 and 60 years. Exclusion Criteria: * individuals previously treated with GLP-1RA medication for any indication * Individuals who have previously undergone bariatric surgery * Individuals with type 1 diabetes

What they're measuring

Exploring the pressence and role of GPCR-autoantibodies in obesity

Timeframe: At the time of enrolement

Trial details

NCT IDNCT07542327

SponsorClaus Bogh Juhl

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-09-01

Contact for this trial

Tobias M Windedal, MD

42957945 tobias.midtvedt.windedal@rsyd.dk

View on ClinicalTrials.gov More Obesity trials